[HTML][HTML] Lower urinary tract symptoms in depression: a review

DJ Anderson, A Aucoin, CR Toups… - Health psychology …, 2023 - ncbi.nlm.nih.gov
Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Pathophysiology, prognosis and treatment of tardive dyskinesia

H Takeuchi, Y Mori, Y Tsutsumi - Therapeutic advances in …, 2022 - journals.sagepub.com
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most
frequently affects the lower face and jaw muscles, but can also affect walking, breathing and …

[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia

American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Antipsychotic-related stigma and the impact on treatment choices: a systematic review and framework synthesis

M Townsend, K Pareja… - Patient preference …, 2022 - Taylor & Francis
Background Antipsychotics are a class of medications primarily used to treat individuals with
psychotic disorders. They have also been indicated for patients with other psychiatric …

[HTML][HTML] Self-stigma and bipolar disorder: A systematic review and best-evidence synthesis

S Favre, H Richard-Lepouriel - Journal of Affective Disorders, 2023 - Elsevier
Background Bipolar disorder is a severe and chronic mental illness characterized by
recurrent major depressive episodes and mania or hypomania. In addition to the burden of …

Contrasting typical and atypical antipsychotic drugs

HY Meltzer, E Gadaleta - Focus, 2021 - Am Psychiatric Assoc
The beliefs that antipsychotic drugs (APDs) are 1) effective only to treat delusions and
hallucinations (positive symptoms), 2) that typical and atypical APDs differ only in ability to …

Assessment of the impact of tardive dyskinesia in clinical practice: consensus panel recommendations

R Jackson, MN Brams, L Citrome… - Neuropsychiatric …, 2021 - Taylor & Francis
Purpose Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients
experience abnormal involuntary movements that can have profound negative impacts on …

Tardive dyskinesia in older persons taking antipsychotics

L Citrome, SH Isaacson, D Larson… - … Disease and Treatment, 2021 - Taylor & Francis
Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by the use of
dopamine receptor-blocking agents (DRBAs), a category of medications that includes first …

[HTML][HTML] Comparative analysis of deutetrabenazine and valbenazine as VMAT2 inhibitors for tardive dyskinesia: a systematic review

M Golsorkhi, J Koch, F Pedouim, K Frei… - Tremor and Other …, 2024 - ncbi.nlm.nih.gov
Background: Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary
movements, often caused by dopamine receptor antagonists. Vesicular Monoamine …

Tardive dyskinesia in Chinese patients with schizophrenia: prevalence, clinical correlates and relationship with cognitive impairment

Q Liang, D Wang, H Zhou, D Chen, M Xiu, L Cui… - Journal of Psychiatric …, 2022 - Elsevier
Objective Tardive dyskinesia (TD) has a high prevalence and is one of the distressing side
effects of antipsychotic medications. Few studies have explored the relationship between …